Form 4: Catalyst Pharmaceuticals Director Reports Stock Transaction
Insider Transaction (Form 4)
Daniel J. Curran, a Director of Catalyst Pharmaceuticals, Inc., reported multiple transactions in common stock on July 15, 2026.
Summary
- Disposition to the issuer: disposed of 40,000 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 18,115 Options to purchase common stock on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 5,468 Restricted Stock Units on July 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Daniel J. Curran — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 40,000 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Options to purchase common stock | 18,115 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Restricted Stock Units | 5,468 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Disposition to the issuer (40,000 shares) |
| 2026-07-15 | Disposition to the issuer (18,115 shares) |
| 2026-07-15 | Disposition to the issuer (5,468 shares) |
Keywords
insider transaction, Form 4, CPRX, CATALYST PHARMACEUTICALS, INC., neutral, Daniel J. Curran
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.